Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...

Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid ...

Medicare Advantage is one of the most comprehensive health care programs in the United States. Many have questions about how ...

Virginia can and should tackle prescription drug affordability, but not with policies that create more problems than they ...

The defendants claim the company breached its ERISA fiduciary duty by putting business interests ahead of the plan and its participants.

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...